US approves Alzheimer’s drug that modestly slows disease

WASHINGTON (AP) — U.S. health officials have approved a new Alzheimer’s drug that modestly slows the brain-robbing disease. The Food and Drug Administration granted the approval Friday for patients in the early stages of Alzheimer’s, but didn’t rule out broader use. It’s the first drug that’s been convincingly shown to slow the decline in memory…